Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Finding the Force of Mentorship: Self-awareness Through Direction - 2Blue Origin's next space tourism flight will break new ground for people with disabilities
- 3Motivational Travel Objections for History Buffs
- 4Solid Propensities: Little Changes for a Superior Life
- 5Flat Earth, spirits and conspiracy theories – experience can shape even extraordinary beliefs
- Investigating Design and Individual Style: Track down Your Remarkable Look
- Language Learning Applications for Voyagers
- The 15 Most Motivating TED Discusses All Time
- Figure out How to Remain Informed about the Most recent Open Record Extra Offers
- The Best Cell phone Brands for Tech Aficionados
- Vote in favor of the Top Vegetable for Senior
- All that You Want to Be familiar with Dental Inserts Centers
- Figure out How to Ascertain the Restitution Time frame for Your Sunlight based chargers
- Find Your Inward Culinary specialist: Cooking Procedures and Recipes
